Filing Flows › 4D Molecular Therapeutics (FDMT) › Recalls, complaints & regulation

4D Molecular Therapeutics (FDMT): clinical trials

4D Molecular Therapeutics (FDMT) beyond its filings: 10 active clinical trials.

4D Molecular Therapeutics' latest quarter

4D Molecular Therapeutics, Q2 2026: revenue $3.8M (252× year over year), net loss $72.9M, operating cash flow −$70.0M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does 4D Molecular Therapeutics have?

10 active studies on ClinicalTrials.gov, 3 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.